PUBLIC COMPANY
saveAscendis Pharma Inc
updated 2mo ago
community read0 votes
🐶 often sniffed alongside
top 4pipeline
2
marketed
1
phase 3
0
catalysts ytd
5
approvals ytd
5
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Marketed1Unknown
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- BioMarin axes asset from $270M Inozyme takeover, ending run in rare metabolic indicationBioMarin’s discontinued drug showed biomarker benefits in a Phase 3 study for ENPP1 deficiency but these failed to translate to clinical improvements.biospace · 7d ago
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that